Pfizer CEO Albert Bourla criticizes RFK's vaccine stance, warns US health research is losing ground to China, and urges ...

Four recent deals fueled more angst about China’s biotech progress, while Pfizer, Bristol Myers and Sarepta all worked to appease jittery investors.

Pfizer on Tuesday joined the cavalcade of big pharma firms hunting for novel weight loss drugs in the laboratories of Chinese biotechs, even as U.S. authorities ramp up efforts to undercut the growing ...

In 2025's third quarter, multiple large vaccine developers, including Pfizer and GSK, saw vaccine sales tick up globally ...

Eli Lilly (LLY), Pfizer (PFE), and Johnson & Johnson (JNJ) secured spots on China's first innovative drug catalog for private insurance, featuring 19 high-cost medicines for conditions like cancer, ...

Chinese drugmaker Fosun Pharma (SFOSF) on Tuesday announced a global licensing agreement with Pfizer (PFE) to hand the U.S. pharma giant exclusive rights to its oral GLP-1 drugs in a deal worth up to ...